- Investing Ideas
- /
- Global Healthcare High Growth Potential Companies
Global Healthcare High Growth Potential Companies
UPDATED Apr 13, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
448 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LALPATHLAB | ₹2,358.40 | 3.2% | 23.6% | ₹195.9b | ₹2,450.11 | PE59.4x | E15.5% | 0.8% | ||
ASCN | CHF8.09 | -0.7% | -5.9% | CHF290.6m | CHF12.17 | PE16.7x | E12.9% | 3.7% | ||
INFU | US$8.04 | -3.2% | -15.4% | US$171.0m | US$14.75 | PE196.1x | E87.8% | n/a | ||
CARE | kr24.90 | -1.2% | 60.6% | kr605.7m | kr28.50 | PE16x | E19.5% | n/a | ||
ALC | CHF74.18 | -2.5% | 15.2% | CHF36.6b | CHF85.51 | PE41.1x | E10.5% | 0.3% | ||
MEDI | kr192.00 | -3.5% | -26.2% | kr3.5b | kr210.00 | PE33.9x | E9.2% | 2.3% | ||
USPH | US$102.70 | -3.5% | -2.3% | US$1.5b | US$119.30 | PE85.3x | E26.9% | 1.7% | ||
MED | €2.66 | 3.9% | -12.5% | €126.4m | €5.10 | PB0.6x | E59.7% | 0% | ||
3600 | HK$4.75 | 13.6% | 61.6% | HK$4.5b | HK$7.19 | PE11.1x | E13.7% | 3.8% | ||
UPR | €2.70 | -1.8% | -8.8% | €737.1m | €4.33 | PE16.4x | E11.1% | 0.7% | ||
ARAY | US$2.28 | -5.0% | -24.0% | US$226.1m | US$8.75 | PB4.7x | E108.5% | n/a | ||
DCGO | US$3.26 | -14.4% | -57.9% | US$339.6m | US$9.89 | PE49.5x | E49.6% | n/a | ||
603987 | CN¥7.44 | -6.1% | -51.8% | CN¥3.3b | n/a | PE13.5x | E24.3% | 3.0% | ||
AVAH | US$2.34 | -10.0% | 87.2% | US$450.2m | US$2.57 | PE-3.3x | E116.8% | n/a | ||
COH | AU$320.06 | -2.0% | 29.0% | AU$21.0b | AU$280.94 | PE59.8x | E12.2% | 1.2% | ||
RHC | AU$52.00 | -3.7% | -23.3% | AU$11.9b | AU$57.22 | PE53.9x | E17.7% | 1.3% |